Our group was one of the first to document that gasdermin D (GSDMD)-driven pyroptosis, a downstream executor of several inflammasomes, is the key inflammatory link between NAFLD and NASH [9]. Here, GSDMD is linked to metabolic dysfunction-associated steatotic liver disease.